Skip to main navigation Skip to search Skip to main content

ENLIGHTEN: A Multicenter, Longitudinal, Open-Label, Single-Arm Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated with Ozanimod (RPC-1063)

University at Buffalo

Project: Research

Project Details

StatusActive
Effective start/end date04/9/20 → 12/31/26

Funding

  • Celgene Corporation: $33,480.00